| Extracellular metabolic energetics can promote cancer progression JM Loo, A Scherl, A Nguyen, FY Man, E Weinberg, Z Zeng, L Saltz, ... Cell 160 (3), 393-406, 2015 | 367 | 2015 |
| Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC JF Colombel, ME Keir, A Scherl, R Zhao, G de Hertogh, WA Faubion, ... Gut 66 (12), 2063-2068, 2017 | 145 | 2017 |
| Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade R Banchereau, AS Chitre, A Scherl, TD Wu, NS Patil, P de Almeida, ... Journal for ImmunoTherapy of Cancer 9 (4), 2021 | 103 | 2021 |
| Impaired phagocytosis in caveolin-1 deficient macrophages J Li, A Scherl, F Medina, PG Frank, RN Kitsis, HB Tanowitz, F Sotgia, ... Cell Cycle 4 (11), 1599-1607, 2005 | 80 | 2005 |
| A practical guide to assess the Nancy histological index for UC A Marchal-Bressenot, A Scherl, J Salleron, L Peyrin-Biroulet Gut 65 (11), 1919-1920, 2016 | 58 | 2016 |
| Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin‐RAS transgenic mice A Scherl, JF Li, RD Cardiff, N Schreiber‐Agus The Prostate 59 (4), 448-459, 2004 | 55 | 2004 |
| Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease B Dai, JA Hackney, R Ichikawa, A Nguyen, J Elstrott, LD Orozco, KH Sun, ... Cell Reports Medicine 2 (8), 2021 | 40 | 2021 |
| Mxi1-SRα: a novel Mxi1 isoform with enhanced transcriptional repression potential C Dugast-Darzacq, M Pirity, JK Blanck, A Scherl, N Schreiber-Agus Oncogene 23 (55), 8887-8899, 2004 | 29 | 2004 |
| AlphaE integrin expression is increased in the ileum relative to the colon and unaffected by inflammation R Ichikawa, CA Lamb, J Eastham-Anderson, A Scherl, L Raffals, ... Journal of Crohn's and Colitis 12 (10), 1191-1199, 2018 | 26 | 2018 |
| Magnetic resonance enterography and histology in patients with fibrostenotic Crohn’s disease: a multicenter study A Coimbra, J Rimola, M Cuatrecasas, G De Hertogh, G Van Assche, ... Clinical and translational gastroenterology, 10.14309, 2022 | 18 | 2022 |
| Inflammatory bowel disease susceptibility gene C1ORF106 regulates intestinal epithelial permeability P Manzanillo, M Mouchess, N Ota, B Dai, R Ichikawa, A Wuster, B Haley, ... Immunohorizons 2 (5), 164-171, 2018 | 14 | 2018 |
| Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer L Taraborrelli, Y Şenbabaoğlu, L Wang, J Lim, K Blake, N Kljavin, ... Nature Communications 14 (1), 5945, 2023 | 9 | 2023 |
| An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseases MM Xie, B Dai, JA Hackney, T Sun, J Zhang, JK Jackman, S Jeet, ... Cell Reports Medicine 4 (8), 2023 | 7 | 2023 |
| IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models JE Heredia, C Sorenson, S Flanagan, V Nunez, C Jones, A Martzall, ... PloS one 17 (9), e0274582, 2022 | 6 | 2022 |
| Etrolizumab induction therapy improves histologic outcomes in anti-TNF failed patients with ulcerative colitis: Results from the Hickory Open Label Induction Cohort DT Rubin, BG Feagan, L Peyrin-Biroulet, RK Pai, YS Oh, U Arulmani, ... Gastroenterology 154, 1366, 2018 | 5 | 2018 |
| Notch signaling in thyrocytes is essential for adult thyroid function and mammalian homeostasis L Mosteiro, TTT Nguyen, S Hankeova, D Alvarez-Sierra, M Reichelt, ... Nature Metabolism 5 (12), 2094-2110, 2023 | 3 | 2023 |
| P136 Association between histological indices and ulcerative colitis activity measures among patients in the HICKORY (etrolizumab) open-label induction cohort L Peyrin-Biroulet, B Feagan, RK Pai, U Arulmani, A Boruvka, YS Oh, ... Journal of Crohn's and Colitis 13 (Supplement_1), S157-S158, 2019 | 2 | 2019 |
| P069 Correlation Between Histologic Indices and Ulcerative Colitis Activity Measures Among Patients in the HICKORY (Etrolizumab) Open-Label Induction Cohort L Peyrin-Biroulet, B Feagan, R Pai, A Boruvka, Y Oh, A Scherl, A Scalori, ... Official journal of the American College of Gastroenterology| ACG 114, S18, 2019 | 1 | 2019 |
| Etrolizumab treatment improves histological activity as assessed by the Robarts histopathology index BG Feagan, G De Hertogh, L Peyrin-Biroulet, DT Rubin, R Maciuca, ... Gastroenterology 152 (5), S600, 2017 | 1 | 2017 |
| P522 A multicenter study to validate Magnetic Resonance Enterography against histological assessments of stenotic disease in patients with Crohn's disease A Coimbra, J Rimola, M Cuatrecasas, G De Hertogh, G Van Assche, ... Journal of Crohn's and Colitis 11 (suppl_1), S345-S345, 2017 | 1 | 2017 |
